Veltio
Updating the operating model
- Biotechnology
- January 2026
A4BEE prepared this analysis from publicly available sources. It reflects our own reading of Veltio's published strategy and is not endorsed by, or produced in cooperation with, Veltio. Company website
Strategic priorities
Veltio operates across 4 stated priorities, with the most concrete near-term plan anchored on sustainability leadership.
Positioning as the solvent-free, renewable material alternative to traditional spray-drying and freeze-drying methods, minimizing environmental impact through algae-derived porous cellulose.
Ensuring compatibility with standard, widely available industrial tablet press equipment to enable rapid technology transfer to any global CDMO without specialized machinery requirements.
Shortening time to market for poorly soluble drugs through direct compression technology that eliminates complex processing steps like rotary evaporation and cryogenic treatments.
-
01
Sustainability Leadership
Positioning as the solvent-free, renewable material alternative to traditional spray-drying and freeze-drying methods, minimizing environmental impact through algae-derived porous cellulose.
-
02
Scalability Through Standardization
Ensuring compatibility with standard, widely available industrial tablet press equipment to enable rapid technology transfer to any global CDMO without specialized machinery requirements.
-
03
Speed to Market
Shortening time to market for poorly soluble drugs through direct compression technology that eliminates complex processing steps like rotary evaporation and cryogenic treatments.
-
04
Innovation Pipeline Expansion
Reviving industrial projects with problematic solubility by continuously expanding the API library beyond 15 tested substances to capture BCS Class II and IV reformulation opportunities.
Challenges we see
- Operations Manufacturing
CDMO Technology Transfer Gap
Veltio relies on external CDMOs for production scaling but transfers technology to partners using legacy equipment lacking high-resolution data acquisition, creating a forensic nightmare when batch failures occur.
When tablets fail dissolution standards, identifying root causes across compression force, humidity, or feedstock variability becomes impossible without real-time process data from partner sites.
- Digital Integration
Siloed Research Data Architecture
Research data is trapped across university lab systems and local files at Uppsala, preventing scientists from accessing real-time performance data from tablet presses at remote partner sites.
The IT/OT divide means meaningful data is only generated after batch completion rather than during processing, eliminating opportunities for real-time quality intervention.
- Operations Operations
Cognitive Overload from Manual Workflows
A four-person team manually manages stability studies, in-vitro dissolution data, and animal trial results across 15+ substances, creating severe bottlenecks as the pipeline grows.
Alert fatigue and cognitive overload from manual processing lead to missed insights in the data, potentially delaying critical decisions on formulation adjustments.
- Compliance Regulatory
FDA/EMA Regulatory Data Integrity
Meeting FDA/EMA bioavailability standards requires proving consistent Tmax and Cmax values across batches, demanding tamper-proof data logging that paper-based or simple digital systems cannot provide.
Without GAMP5-compliant automated data logging, Veltio faces compliance warning risks that could delay market approvals and damage investor confidence.
- Digital Integration
Intellectual Property Cybersecurity Exposure
Veltio's entire valuation rests on ten patent families and proprietary algae cellulose compositions, yet technical transfers to global partners expose core IP without Zero Trust security protocols.
As the company handles sensitive oncology and immune disorder drug data, a single data breach during technology transfer could severely damage company valuation and competitive positioning.
Opportunities, by urgency and business impact
Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.
-
Lab-to-Pilot Data Continuity
Research data from Uppsala University labs does not follow substances through pilot-scale compression at partner sites, creating data gaps that slow troubleshooting and formulation optimization.
Implement a digital thread architecture that captures analytical equipment outputs (XRD, DSC, FTIR, dissolution testers) and correlates them with production parameters across the entire development lifecycle.
-
Real-Time Manufacturing Visibility
Standard tablet presses at CDMO sites lack connectivity to Veltio's systems, preventing remote monitoring of critical process parameters like compression force that determine nanopore integrity.
Deploy IoT-enabled process monitoring with OPC UA connectivity to create a unified view of manufacturing operations across distributed partner sites in France, US, and Mexico.
-
Regulatory Compliance Automation
Manual data management cannot provide the audit-ready, tamper-proof documentation required for FDA/EMA submissions proving consistent bioavailability profiles across production batches.
Implement GAMP5/FDA-compliant automated data logging through bioprocess Control that ensures data integrity from sensor to regulatory submission without manual intervention.
-
ESG Performance Tracking
Veltio positions itself as a sustainable alternative to solvent-based methods but lacks automated systems to audit and document environmental claims across its decentralized supply chain.
Build an ESG digital tracking platform that quantifies carbon footprint reduction versus traditional spray-drying, supporting investor relations and EU regulatory compliance (NIS2, CSRD).
-
Secure Technology Transfer
Sharing proprietary formulation data with global CDMO partners exposes critical intellectual property through unsecured technical transfer processes without identity-based access controls.
Implement Zero Trust security architecture ensuring patent-protected compositions remain confidential even when shared with external manufacturing partners during technology transfer.
What we'd propose
- Digital Lab
Digital Lab Integration Platform
A comprehensive data integration solution connecting Uppsala University research systems with pilot-scale production equipment to create smooth data continuity from discovery through manufacturing.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital CDMO
CDMO Remote Monitoring System
An IoT-enabled manufacturing visibility platform that connects Veltio to tablet press operations at partner CDMO sites, providing real-time process monitoring without requiring equipment replacement.
-
OT/IT convergence
DETAIL
-
Batch intelligence
DETAIL
-
Production release flow
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Enterprise AI
GxP Compliance Data Platform
A GAMP5/FDA-compliant data management system providing tamper-proof documentation and automated audit trails for regulatory submissions demonstrating bioavailability consistency.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Enterprise AI
Sustainability Performance Portal
An ESG tracking and reporting platform that quantifies and documents Veltio's environmental advantages over traditional solvent-based manufacturing methods across the distributed supply chain.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Enterprise AI
Zero Trust IP Protection Framework
A comprehensive cybersecurity architecture implementing identity-based access controls and encrypted data sharing to protect proprietary formulation data during technical transfers to CDMO partners.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
Digital maturity: today and target
Scored out of 100 across six dimensions. The target is what Veltio's own published ambition implies — not a perfect score.
- Data Integration 25 → 80
- Research data siloed across university systems and local files; no unified data platform connecting lab to production
- Process Automation 30 → 75
- Manual management of 15+ substance pipeline creates bottlenecks; no automated data pipelines from analytical equipment
- Real-Time Visibility 20 → 85
- No remote monitoring capability for CDMO production; data available only post-batch rather than during processing
- Regulatory Compliance 35 → 90
- Basic documentation exists but lacks GAMP5-compliant automated audit trails required for FDA/EMA submissions
- Cybersecurity 25 → 80
- No Zero Trust architecture for IP protection; technical transfers expose proprietary data without access controls
- Sustainability Tracking 20 → 70
- Environmental claims not backed by automated measurement; no ESG tracking infrastructure for NIS2/CSRD compliance
Check this yourself
Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.
-
Self-assessment
Find Your LIMS
Answer a few questions about your lab and get a shortlist of LIMS that fit it.
-
Self-assessment
Electronic Batch Record (eBR) Readiness
Check how far your batch records are from paperless, and what the next step is.
-
Market comparison
Digital Lab: Equipment & Integration Map
Which lab instruments connect to which systems, and where the gaps usually are.
-
Market comparison
European CDMOs Compared
The 2026 landscape: who does what, at what scale.
Think we've read this right?
Talk to usRelated reading
-
Still biotech or already techbio?
The results of a Tech Imperatives for biotech 2022 report indicate changes in biotech production and management.
-
Accelerating lab and manufacturing operations with MTP – a modular approach
Among the various modular and plug-n-produce approaches, the Modular Type Package (MTP) approach has emerged as a game-changer.
-
Zero Trust Security Principles
The drive to find new resources for innovation and process improvement in life science companies is becoming more based on technologies.
-
From Paper to Performance: Operational Efficiency and Compliance in Labs
Transform your QC lab with scalable digital solutions that embed compliance, boost efficiency, and deliver a future-ready competitive edge.
-
OPC UA protocol support in embedded systems
OPC Unified Architecture (OPC UA) is a modern standard for data exchange, increasingly used in industrial environments.
This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with Veltio, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].